KR102425709B1 - Dp 길항제 - Google Patents

Dp 길항제 Download PDF

Info

Publication number
KR102425709B1
KR102425709B1 KR1020217008017A KR20217008017A KR102425709B1 KR 102425709 B1 KR102425709 B1 KR 102425709B1 KR 1020217008017 A KR1020217008017 A KR 1020217008017A KR 20217008017 A KR20217008017 A KR 20217008017A KR 102425709 B1 KR102425709 B1 KR 102425709B1
Authority
KR
South Korea
Prior art keywords
compound
general formula
group
phenyl
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020217008017A
Other languages
English (en)
Korean (ko)
Other versions
KR20210065944A (ko
Inventor
마사키 아사다
게이스케 하나다
사토노리 히구치
아츠시 나가나와
야스히로 다케다
Original Assignee
오노 야꾸힝 고교 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오노 야꾸힝 고교 가부시키가이샤 filed Critical 오노 야꾸힝 고교 가부시키가이샤
Priority to KR1020227025551A priority Critical patent/KR20220107330A/ko
Publication of KR20210065944A publication Critical patent/KR20210065944A/ko
Application granted granted Critical
Publication of KR102425709B1 publication Critical patent/KR102425709B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/56—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/64—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/48—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D309/06—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Auxiliary Devices For Music (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020217008017A 2018-09-20 2019-09-19 Dp 길항제 Active KR102425709B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020227025551A KR20220107330A (ko) 2018-09-20 2019-09-19 Dp 길항제

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018175758 2018-09-20
JPJP-P-2018-175758 2018-09-20
PCT/JP2019/036725 WO2020059790A1 (ja) 2018-09-20 2019-09-19 Ｄｐアンタゴニスト

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020227025551A Division KR20220107330A (ko) 2018-09-20 2019-09-19 Dp 길항제

Publications (2)

Publication Number Publication Date
KR20210065944A KR20210065944A (ko) 2021-06-04
KR102425709B1 true KR102425709B1 (ko) 2022-07-28

Family

ID=69888481

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020217008017A Active KR102425709B1 (ko) 2018-09-20 2019-09-19 Dp 길항제
KR1020227025551A Withdrawn KR20220107330A (ko) 2018-09-20 2019-09-19 Dp 길항제

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020227025551A Withdrawn KR20220107330A (ko) 2018-09-20 2019-09-19 Dp 길항제

Country Status (17)

Country Link
US (3) US11319296B2 (https=)
EP (1) EP3854781B1 (https=)
JP (2) JP7021709B2 (https=)
KR (2) KR102425709B1 (https=)
CN (1) CN112739680A (https=)
AU (1) AU2019341082A1 (https=)
BR (1) BR112021005260A2 (https=)
CA (1) CA3113210A1 (https=)
ES (1) ES2982217T3 (https=)
IL (2) IL310383A (https=)
MX (1) MX2021003131A (https=)
NZ (1) NZ774113A (https=)
PH (1) PH12021550549A1 (https=)
SG (1) SG11202102566YA (https=)
TW (2) TWI822457B (https=)
WO (1) WO2020059790A1 (https=)
ZA (1) ZA202101887B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019341082A1 (en) * 2018-09-20 2021-04-15 Ono Pharmaceutical Co., Ltd. DP antagonist
TW202146394A (zh) * 2020-03-19 2021-12-16 日商小野藥品工業股份有限公司 苯乙酸化合物之結晶
JP2024016311A (ja) * 2020-12-24 2024-02-07 小野薬品工業株式会社 Ｅｐ２アンタゴニスト

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003078409A1 (en) 2002-03-19 2003-09-25 Ono Pharmaceutical Co., Ltd. Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
WO2005028455A1 (ja) 2003-09-17 2005-03-31 Ono Pharmaceutical Co., Ltd. カルボン酸化合物およびそれらを有効成分として含有する医薬組成物
WO2005080367A1 (en) 2004-02-12 2005-09-01 Pharmagene Laboratories Limited Ep2 receptor agonists
WO2009022687A1 (ja) 2007-08-10 2009-02-19 Ono Pharmaceutical Co., Ltd. フェニル酢酸化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005779A1 (en) * 1985-04-03 1986-10-09 Yamanouchi Pharmaceutical Co., Ltd. Phenylene derivatives
JPS63159342A (ja) 1985-04-03 1988-07-02 Yamanouchi Pharmaceut Co Ltd 新規カルボン酸化合物
WO2006007448A2 (en) 2004-06-17 2006-01-19 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions and related methods of use
US8765733B2 (en) 2011-09-26 2014-07-01 Gruenenthal Gmbh Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands
WO2018116107A1 (en) 2016-12-20 2018-06-28 Glaxosmithkline Intellectual Property Development Limited Modulators of indoleamine 2,3-dioxygenase
JP6533249B2 (ja) 2017-04-21 2019-06-19 山佐株式会社 遊技機用基板ケースの取り付け構造及び遊技機
US20210139467A1 (en) 2017-06-28 2021-05-13 Glaxosmithkline Intellectual Property Development Limited Modulators of indoleamine 2,3-dioxygenase
AU2019341082A1 (en) * 2018-09-20 2021-04-15 Ono Pharmaceutical Co., Ltd. DP antagonist

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003078409A1 (en) 2002-03-19 2003-09-25 Ono Pharmaceutical Co., Ltd. Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
WO2005028455A1 (ja) 2003-09-17 2005-03-31 Ono Pharmaceutical Co., Ltd. カルボン酸化合物およびそれらを有効成分として含有する医薬組成物
WO2005080367A1 (en) 2004-02-12 2005-09-01 Pharmagene Laboratories Limited Ep2 receptor agonists
WO2009022687A1 (ja) 2007-08-10 2009-02-19 Ono Pharmaceutical Co., Ltd. フェニル酢酸化合物

Also Published As

Publication number Publication date
CA3113210A1 (en) 2020-03-26
NZ774113A (en) 2024-09-27
ES2982217T3 (es) 2024-10-15
KR20210065944A (ko) 2021-06-04
US20220204468A1 (en) 2022-06-30
JP2022058610A (ja) 2022-04-12
US11319296B2 (en) 2022-05-03
CN112739680A (zh) 2021-04-30
US20250042870A1 (en) 2025-02-06
EP3854781A4 (en) 2022-02-23
MX2021003131A (es) 2021-05-14
EP3854781B1 (en) 2024-05-22
JP7338711B2 (ja) 2023-09-05
KR20220107330A (ko) 2022-08-02
AU2019341082A1 (en) 2021-04-15
SG11202102566YA (en) 2021-04-29
TW202023535A (zh) 2020-07-01
TWI822457B (zh) 2023-11-11
TWI784199B (zh) 2022-11-21
US20220033371A1 (en) 2022-02-03
WO2020059790A1 (ja) 2020-03-26
IL310383A (en) 2024-03-01
PH12021550549A1 (en) 2022-02-14
JP7021709B2 (ja) 2022-02-17
ZA202101887B (en) 2022-10-26
TW202308986A (zh) 2023-03-01
IL281433A (en) 2021-04-29
BR112021005260A2 (pt) 2021-06-15
EP3854781A1 (en) 2021-07-28
JPWO2020059790A1 (ja) 2021-09-02

Similar Documents

Publication Publication Date Title
JP7338711B2 (ja) Ｄｐアンタゴニスト
AU2015336458B2 (en) KCNQ2-5 channel activator
JP7750341B2 (ja) Ａｂｈｄ６アンタゴニスト
JP6197971B1 (ja) Ｋｃｎｑ２〜５チャネル関連疾患の予防および／または治療剤
RU2803243C2 (ru) Антагонист dp
JP7047954B2 (ja) フェニル酢酸化合物を含有する医薬組成物
RU2857204C2 (ru) Антагонист abhd6
HK40051095A (en) Dp antagonist
JP7852604B2 (ja) Ａｂｈｄ６アンタゴニストを含有する医薬組成物
US20260083735A1 (en) Abhd6 antagonist
JP2024052624A (ja) Ａｂｈｄ６アンタゴニストを含有する医薬組成物
WO2026075117A1 (en) Bridged bicyclic compounds

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20210317

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
A302 Request for accelerated examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20220504

Comment text: Request for Examination of Application

PA0302 Request for accelerated examination

Patent event date: 20220504

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20220523

A107 Divisional application of patent
GRNT Written decision to grant
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20220722

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220722

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220725

End annual number: 3

Start annual number: 1

PG1601 Publication of registration